Abstract:Understanding mechanisms of ageing remains a complex challenge for biogerontologists, but recent adaptations of evolutionary ageing theories offer a compelling lens in which to view both age-related molecular and physiological deterioration. Ageing is commonly associated with progressive declines in biochemical and molecular processes resulting from damage accumulation, yet the role of continued developmental gene activation is less appreciated. Natural selection pressures are at their highest in youthful periods to modify gene expression towards maximising reproductive capacity. After sexual maturation, selective pressure diminishes, subjecting individuals to maladaptive pleiotropic gene functions that were once beneficial for developmental growth but become pathogenic later in life. Due to this selective 'shadowing' in ageing, mechanisms to counter such hyper/hypofunctional genes are unlikely to evolve. Interventions aimed at targeting gene hyper/hypofunction during ageing might, therefore, represent an attractive therapeutic strategy. The nematode Caenorhabditis elegans offers a strong model for post-reproductive mechanistic and therapeutic investigations, yet studies examining the mechanisms of, and countermeasures against, ageing decline largely intervene from larval stages onwards. Importantly, however, lifespan extending conditions frequently impair early-life fitness and fail to correspondingly increase healthspan. Here, we consolidate multiple evolutionary theories of ageing and discuss data supporting hyper/hypofunctional changes at a global molecular and functional level in C. elegans, and how classical lifespan-extension mutations alter these dynamics. The relevance of such mutant models for exploring mechanisms of ageing are discussed, highlighting that post-reproductive gene optimisation represents a more translatable approach for C. elegans research that is not constrained by evolutionary trade-offs. Where some genetic mutations in C. elegans that promote late-life health map accordingly with healthy ageing in humans, other widely used genetic mutations that extend worm lifespan are associated with life-limiting pathologies in people. Lifespan has also become the gold standard for quantifying 'ageing', but we argue that gerospan compression (i.e., 'healthier' ageing) is an appropriate goal for anti-ageing research, the mechanisms of which appear distinct from those regulating lifespan alone. There is, therefore, an evident need to re-evaluate experimental approaches to study the role of hyper/hypofunctional genes in ageing in C. elegans.

The research aiming to keep people healthier for longer

Ageing with elegans: a research proposal to map healthspan pathways

Of Mice, Whales, Jellyfish and Men: In Pursuit of Increased Longevity

Promoting Health and Longevity through Diet: From Model Organisms to Humans

Focus on senescence: Clinical significance and practical applications

Antiaging Strategies and Remedies: A Landscape of Research Progress and Promise

Aging research comes of age

Ageing as a two-phase process: theoretical framework

Ageing, microbes and health

Consolidating multiple evolutionary theories of ageing suggests a need for new approaches to study genetic contributions to ageing decline

Two conserved epigenetic regulators prevent healthy ageing

Ethical concerns in aging research: perspectives of global frontline researchers

Gut microbiota and healthy longevity

Extending Healthy Life Span—From Yeast to Humans

The landscape of aging

Gut microbiome and aging nexus and underlying mechanism

Biological Restraints on Indefinite Survival

Research progress on aging mechanism and drugs and the role of stem cells in anti-aging process

Unraveling female reproductive senescence to enhance healthy longevity

Meta-analytic Insights into the Effects of Different Anti-aging Drugs on Survival Curves of Caenorhabditis elegans

Searching for Beauty and Health: Aging in Women, Nutrition, and the Secret in Telomeres